NTI.AX
Price:
$0.016
Market Cap:
$16.16M
Neurotech International Limited (NTI.AX), along with its subsidiaries, is an Australian firm dedicated to the research, development, and manufacture of innovative medical devices and solutions. The company's primary focus lies in advancing and commercializing its Mente platform, a technological system designed to monitor and facilitate home-based therapies. This includes its Mente Autism product, specifically aimed at the diagnosis and treatment of autism spectrum disorder. Additionally, Neurotech actively undertakes various medical research projects and engineers new technological instruments. The company was established in 2016 and maintains its headquarters in Nedlands, Australia.
Industry
Medical - Devices
IPO Date
2016-11-03
Stock Exchange
ASX
Ticker
NTI.AX
According to Neurotech International Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.22. This represents a change of -55.83% compared to the average of -0.50 of the last 4 quarters.
The mean historical PE Ratio of Neurotech International Limited over the last ten years is -5.29. The current -0.22 PE Ratio has changed 315.98% with respect to the historical average. Over the past ten years (40 quarters), NTI.AX's PE Ratio was at its highest in in the December 2025 quarter at 5.00. The PE Ratio was at its lowest in in the December 2023 quarter at -21.56.
Average
-5.29
Median
-3.81
Minimum
-14.58
Maximum
-0.52
Discovering the peaks and valleys of Neurotech International Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 387.00%
Maximum Annual PE Ratio = -0.52
Minimum Annual Increase = -88.40%
Minimum Annual PE Ratio = -14.58
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.47 | -88.40% |
| 2024 | -12.68 | 210.62% |
| 2023 | -4.08 | -72.01% |
| 2022 | -14.58 | 315.49% |
| 2021 | -3.51 | 387.00% |
| 2020 | -0.72 | 39.34% |
| 2019 | -0.52 | -85.48% |
| 2018 | -3.56 | -12.39% |
| 2017 | -4.07 | -47.17% |
The current PE Ratio of Neurotech International Limited (NTI.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.08
5-year avg
-7.26
10-year avg
-5.29
Neurotech International Limited’s PE Ratio is greater than Atomo Diagnostics Limited (-2.86), less than Althea Group Holdings Limited (0), greater than TruScreen Group Limited (-5.16), greater than Control Bionics Limited (-3.35), greater than OncoSil Medical Ltd (-1.53), less than Enlitic, Inc. (-0.06), greater than BTC Health Limited (-20.37), greater than Patrys Limited (-3.19), less than MedAdvisor Limited (-0.17), greater than Tissue Repair Ltd (-1.73),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.86 | $14.44M | |
| 0 | $16.91M | |
| -5.16 | $9.88M | |
| -3.35 | $22.04M | |
| -1.53 | $27.23M | |
| -0.06 | $5.83M | |
| -20.37 | $17.05M | |
| -3.19 | $12.95M | |
| -0.17 | $14.00M | |
| -1.73 | $6.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurotech International Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neurotech International Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Neurotech International Limited's PE Ratio?
How is the PE Ratio calculated for Neurotech International Limited (NTI.AX)?
What is the highest PE Ratio for Neurotech International Limited (NTI.AX)?
What is the 3-year average PE Ratio for Neurotech International Limited (NTI.AX)?
What is the 5-year average PE Ratio for Neurotech International Limited (NTI.AX)?
How does the current PE Ratio for Neurotech International Limited (NTI.AX) compare to its historical average?